Clinical Trial Update: Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring Envafolimab as first-line treatment in aged patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Envafolimab (envafolimab)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Non-small Cell Lung Cancer Stage IV | Phase 2 | Status: UNKNOWN